ADVM - Adverum Biotechnologies - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ADVM is currently covered by 4 analysts with an average price target of $-3.1. This is a potential upside of $-7.91 (-164.45%) from yesterday's end of day stock price of $4.81.

Adverum Biotechnologies's activity chart (see below) currently has 31 price targets and 52 ratings on display. The stock rating distribution of ADVM is 25% HOLD and 75% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 74.76% with an average time for these price targets to be met of 401.92 days.

Highest price target for ADVM is $12, Lowest price target is $4, average price target is $8.

Most recent stock forecast was given by MATTHEW CAUFIELD from HC WAINWRIGHT on 23-Sep-2025. First documented stock forecast 16-Jun-2015.

Currently out of the existing stock ratings of ADVM, 3 are a HOLD (25%), 9 are a BUY (75%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

20 days ago
(23-Sep-2025)

0/4 (0%)

$23.75 (380.00%)

Buy

2 months ago
(13-Aug-2025)

3/4 (75%)

$30.52 (321.94%)

884

Buy

$12

$7.19 (149.48%)

$16

3 months 18 days ago
(25-Jun-2025)

1/4 (25%)

$9.42 (365.12%)

292

Hold

$4

$-0.81 (-16.84%)

$5

4 months 28 days ago
(15-May-2025)

3/5 (60%)

$1.95 (95.12%)

127

Buy

$6

$4.05 (207.69%)

$4

2 years 1 months 8 days ago
(05-Sep-2023)

4/7 (57.14%)

$4.22 (237.08%)

196

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is ADVM (Adverum Biotechnologies) average time for price targets to be met?

On average it took 401.92 days on average for the stock forecasts to be realized with a an average price target met ratio 74.76

Which analyst has the current highest performing score on ADVM (Adverum Biotechnologies) with a proven track record?

CHARLES DUNCAN

Which analyst has the most public recommendations on ADVM (Adverum Biotechnologies)?

Charles Duncan works at CANTOR FITZGERALD and has 12 price targets and 8 ratings on ADVM

Which analyst is the currently most bullish on ADVM (Adverum Biotechnologies)?

Biren Amin with highest potential upside - $46.19

Which analyst is the currently most reserved on ADVM (Adverum Biotechnologies)?

Luca Issi with lowest potential downside - -$0.81

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?